_:ncec9f95e2efa4526923bfd6716ba5186xb1
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/179/algernon-neuroscience-announces-u-s-sec-qualification-of>